HER2 IHC Test for Breast & Gastric Cancer | Lahalak
A vital test for targeted therapy in breast and gastric cancers. It detects HER2 protein overexpression to ensure the most effective immunotherapy selection and improve survival outcomes.
Scientific name: HER2 Immunohistochemistry Test
Immunohistochemical (IHC) testing for human epidermal growth factor receptor 2 (HER2/neu) aims to detect overexpression of HER2 on the cell membrane of breast and gastric cancers. This test is a crucial first step (followed by in situ hybridization - ISH in borderline cases) in determining patient eligibility for anti-HER2 antibody therapy, a globa...
Service type
Laboratory test (Tissue)
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Detailed analysis to detect HER2 receptor protein expression in tissue samples
- Consult a pathologist or oncologist to interpret the results.
- Personal support services from Lahalak
Medical Service Information
Conditions & Notices
- Fasting is not required, as the sample is tissue (biopsy or excision).
- The tissue sample must be immediately preserved in 10% standard neutral formalin for 6-72 hours to ensure optimal fixation (this is a critical condition for the accuracy of the results).
- The analysis must be carried out in an accredited and specialized laboratory in accordance with strict international protocols (such as ASCO/CAP).
- This analysis is required compulsorily with ER and PR as part of the basic package for breast cancer characterization.
Medical services you might also like
